An update to the pathogenesis for monoclonal gammopathy of renal significance

Area of Science:

• Nephrology
• Immunology
• Pathology

Background:

• Monoclonal gammopathy of renal significance (MGRS) is a kidney disease caused by toxic monoclonal immunoglobulins from B-cell clones.
• MGRS affects glomeruli, tubules, and vessels, leading to renal damage.
• The pathogenesis involves immunoglobulin deposition, complement activation, and potentially other factors like inflammation and viral infections.

Purpose of the Study:

• To review the current understanding of the mechanisms behind MGRS-related kidney lesions.
• To highlight the role of monoclonal immunoglobulins and complement in MGRS pathogenesis.
• To provide insights into the complex factors contributing to MGRS development.

Main Methods:

• Literature review of MGRS pathogenesis.
• Analysis of mechanisms involving monoclonal immunoglobulin properties (hydrophobicity, glycosylation, isoelectric point).
• Discussion of complement system involvement, particularly the alternative pathway in C3 glomerulopathy with monoclonal glomerulopathy.

Main Results:

• Monoclonal immunoglobulin properties facilitate tissue deposition and glomerular damage.
• Complement deposition is observed in MGRS, especially in C3 glomerulopathy with monoclonal glomerulopathy.
• Alternative pathway dysregulation, auto-antibodies, and direct C3 cleavage by monoclonal immunoglobulin contribute to MGRS.

Conclusions:

• MGRS pathogenesis is multifactorial, involving monoclonal immunoglobulin properties and complement dysregulation.
• Understanding these mechanisms is crucial for diagnosing and managing MGRS.
• Further research into inflammatory and infectious factors may elucidate additional pathogenic pathways.